CannLabs, Inc.
CANL · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 38% | 15% | 10.7% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 47% | 53.4% | 45.1% | 57.9% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 20.1% | 22.7% | 19.2% | 32.4% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 19.8% | 22.4% | 18.8% | 32.2% |
| EPS Diluted | 0.001 | 0.001 | 0.001 | 0.013 |
| % Growth | 22.2% | -18.2% | -91.5% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | $0 | $0 | -$0 | $0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |